Stericycle (NASDAQ: SRCL) reported Q1 EPS of $1.21, $0.16 better than the analyst estimate of $1.05. Revenue for the quarter came in at $895 million versus the consensus estimate of $883.33 million.

FIRST-QUARTER HIGHLIGHTS COMPARED TO PRIOR YEAR:

• Revenues of $895.0 million, an increase of 0.3%, driven by continued growth in Secure Information Destruction, Retail Hazardous Waste and Hospital Compliance Services
• Gross profit of $358.5 million, a decrease of 2.8%, given the expected impact of pricing of small quantity medical waste customers
• Diluted earnings per share (“EPS”) of $0.25, a decrease of 59.7%, due to certain non-recurring adjusted items partially offset by the favorable impact of U.S. tax reform. Adjusted diluted earnings per share (“Adjusted EPS”) of $1.21, an increase of 11.0%, as a result of strong performance in the quarter and the favorable impact of U.S. tax reform

GUIDANCE:

Stericycle sees FY2018 EPS of $4.45-$4.85, versus the consensus of $4.55. Stericycle sees FY2018 revenue of $3.5-3.64 billion, versus the consensus of $3.56 billion.

For earnings history and earnings-related data on Stericycle (SRCL) click here.